Skip to content Skip to navigation

News and Press Releases

Apr 19 2019 | Stanford News
Up to half of people who should be screened for colorectal cancer do not get the routine procedure. A blood test to detect colorectal cancer being developed by Stanford doctors and materials scientists could help change that.
Recent Stanford research on the importance of a particular gene in aging can be traced to a casual conversation between roommates.
Apr 10 2019 | Stanford Medicine
In preclinical trials, Stanford scientists and their collaborators harnessed the breakthrough gene-editing system to replace the mutated gene underpinning the devastating immune disease.
Stanford scientists and collaborators have harnessed CRISPR to replace the mutated gene underpinning the devastating immune disease, SCID-X1.
Apr 8 2019 | Stanford ChEM-H
Baker Family Co-Director of Stanford ChEM-H, Carolyn Bertozzi, has been recognized with the 2019 Gustavus John Esselen Award for Chemistry in the Public Interest for her work in manipulating the complex sugar coating on cell surfaces.
This In the Spotlight features Kyle Loh, a stem cell researcher who is working to create pure populations of cells. He also enjoys road bicycling.
Brain cells called microglia keep brains young by eliminating accumulations of protein debris. But their garbage-colllection ability fades with age.
Apr 3 2019 | Stanford Medicine
Brain cells called microglia serve as the brain’s garbage crew, scarfing up bits of cellular debris. But their underperformance in aging brains contributes to neurodegeneration. Now, a possible workaround?
By scouting for a particular immune cell in the blood, scientists can tell which patients with a lung-scarring disease are at higher risk for death.
Apr 1 2019 | Stanford ChEM-H
In his own words, Felix Alfonso, a trainee in the Stanford ChEM-H Chemistry/Biology Interface (CBI) Program, describes the connections that tie together his Stanford experience.
Mar 29 2019 | Stanford News
While tuberculosis testing is now routine, standard tests don’t work for kids, people with HIV/AIDS and others who struggle to cough anything up from their lungs. A Stanford team is developing a new test to fill the gap.
One night Jim Spudich knocked off a few chapters of a murder mystery before falling asleep, to awaken with a vision that would solve a medical mystery.
Mar 25 2019 | Stanford ChEM-H
A team led by Carolyn Bertozzi, the Baker Family Co-Director of Stanford ChEM-H, developed a tool to help cut down and study mucins, stubborn structures on cell surfaces that help cancers evade detection.
Stanford Medicine's Discovery Innovation Awards provide funding for faculty members pursuing basic science that is "high-risk, high-reward."
Mar 20 2019 | Stanford Medicine
On Dec. 14, 2014, after many months of not getting expected results, biochemist Jim Spudich got into bed, read a chunk of a novel, fell asleep and had a dream that would change the focus of his entire field in thinking about what causes a common and often lethal heart defect.
Forty years ago, Michael Longaker was a guard on the championship winning Michigan State basketball team. Now, he is a Stanford surgeon.
Scientists have modified immune cells, imbuing them with the ability to not only detect, but reveal, the presence of a tumor.
Scientists studying cell death are working to understand how the body protects itself from disease and use that information to form better treatments.
Mar 18 2019 | Stanford Medicine
Stanford scientists were able to engineer immune cells known as macrophages to detect and flag cancer in mice. The researchers hope the technique can be used for early cancer diagnostics in humans.
Mar 14 2019 | Stanford Medicine
Stanford researchers have found a way to predict who will suffer heart problems from a common breast-cancer drug, as well as identified an FDA-approved medication that could mitigate those side effects.

Pages

Subscribe to